Thursday, August 22, 2024 • Boston, MA
AI Showcase for Drug Development and Advances in Fibrosing Lung Disease
The IPF Summit is the industry’s largest drug development initiative for the pulmonary fibrosis community. The event unites pulmonary fibrosis drug developers, clinicians and academic thought leaders, all dedicated to bringing better drugs to patients faster.
In her session “AI Showcase for Drug Development and Advances in Fibrosing Lung Disease,” OSIC Executive Director Elizabeth Estes shared insights on how robust clinical data curation, global normalization and advanced data power can drive radical progress in drug development for fibrosing lung diseases.
In her session “AI Showcase for Drug Development and Advances in Fibrosing Lung Disease,” OSIC Executive Director Elizabeth Estes shared insights on how robust clinical data curation, global normalization and advanced data power can drive radical progress in drug development for fibrosing lung diseases.